Genedrive and partners awarded grant for development of new test

Near-patient molecular diagnostics company Genedrive announced the receipt of a multi-partner grant award from the UK National Institute for Health Research's Invention for Innovation programme on Wednesday, for the development and implementation of a point-of-care pharmacogenetic test to avoid antibiotic-related hearing loss in newborn children. The AIM-traded firm said that, due to an identified genetic predisposition, certain individuals developed irreversible hearing loss when exposed to ...

Den vollständigen Artikel lesen ...